Case Report: SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis

被引:3
作者
Meng, Xiangpeng [1 ]
Ma, Jia [2 ]
Meng, Nan [3 ]
Yun, Tianyu [3 ]
Niu, Beifang [3 ,4 ,5 ]
机构
[1] China Med Univ, Pancreat Endocrinol Ward, Dept Gen Surg, Shengjing Hosp, Shenyang, Peoples R China
[2] China Med Univ, Affiliated Hosp 4, Dept Gastroenterol, Shenyang, Peoples R China
[3] Beijing ChosenMed Clin Lab Co Ltd, Beijing, Peoples R China
[4] Chinese Acad Sci, Comp Network Informat Ctr, Beijing, Peoples R China
[5] Univ Chinese Acad Sci, Beijing, Peoples R China
关键词
SMARCA4; BRG1; SWI; SNF; gallbladder carcinoma; case report; SMALL-CELL CARCINOMA; SWI/SNF COMPLEX; FANCONI-ANEMIA; PIK3CA MUTATIONS; CANCER; EXPRESSION; OVARY; INHIBITION; RISK; GAIN;
D O I
10.3389/fonc.2023.1086266
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
SMARCA4 (BRG1)-deficient undifferentiated carcinoma is a rare and highly aggressive malignancy. It has been reported to occur in a multiple range of organs. However, to the best of our knowledge, SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder has not yet been reported. Here, we describe a case of SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder. Through comprehensive genetic analysis, we hypothesized that in addition to SMARCA4 (BRG1) deficiency, other genetic changes might also be involved in the tumorigenesis of undifferentiated gallbladder cancer in this patient, particularly somatic mutations in the CTNNB1, KRAS, PIK3CA, TP53, CREBBP, and FANCI genes. To the best of our knowledge, this is the first report of SMARCA4 (BRG1)-deficient undifferentiated carcinoma of gallbladder with genetic analysis.
引用
收藏
页数:7
相关论文
共 44 条
[1]   PIK3CA mutations are mutually exclusive with PTEN loss in diffuse large B-cell lymphoma [J].
Abubaker, J. ;
Bavi, P. P. ;
Al-Harbi, S. ;
Siraj, A. K. ;
Al-Dayel, F. ;
Uddin, S. ;
Al-Kuraya, K. .
LEUKEMIA, 2007, 21 (11) :2368-2370
[2]   SMARCA4-deficient Sinonasal Carcinoma A Series of 10 Cases Expanding the Genetic Spectrum of SWI/SNF-driven Sinonasal Malignancies [J].
Agaimy, Abbas ;
Jain, Deepali ;
Uddin, Nasir ;
Rooper, Lisa M. ;
Bishop, Justin A. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2020, 44 (05) :703-710
[3]   SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1neg/CK7pos/HepPar-1pos immunophenotype [J].
Agaimy, Abbas ;
Fuchs, Florian ;
Moskalev, Evgeny A. ;
Sirbu, Horia ;
Hartmann, Arndt ;
Haller, Florian .
VIRCHOWS ARCHIV, 2017, 471 (05) :599-609
[4]   Loss of expression of the SWI/SNF complex is a frequent event in undifferentiated/dedifferentiated urothelial carcinoma of the urinary tract [J].
Agaimy, Abbas ;
Bertz, Simone ;
Cheng, Liang ;
Hes, Ondrej ;
Junker, Kerstin ;
Keck, Bastian ;
Lopez-Beltran, Antonio ;
Stoeckle, Michael ;
Wullich, Bernd ;
Hartmann, Arndt .
VIRCHOWS ARCHIV, 2016, 469 (03) :321-330
[5]   SWI/SNF Complex-deficient Undifferentiated/Rhabdoid Carcinomas of the Gastrointestinal Tract A Series of 13 Cases Highlighting Mutually Exclusive Loss of SMARCA4 and SMARCA2 and Frequent Co-inactivation of SMARCB1 and SMARCA2 [J].
Agaimy, Abbas ;
Daum, Ondrej ;
Maerkl, Bruno ;
Lichtmannegger, Ines ;
Michal, Michal ;
Hartmann, Arndt .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2016, 40 (04) :544-553
[6]   XPG mRNA Expression Levels Modulate Prognosis in Resected Non-Small-Cell Lung Cancer in Conjunction with BRCA1 and ERCC1 Expression [J].
Bartolucci, Roberta ;
Wei, Jia ;
Sanchez, Jose Javier ;
Perez-Roca, Laia ;
Chaib, Imane ;
Puma, Francesco ;
Farabi, Raffaele ;
Mendez, Pedro ;
Roila, Fausto ;
Okamoto, Tatsuro ;
Taron, Miquel ;
Rosell, Rafael .
CLINICAL LUNG CANCER, 2009, 10 (01) :47-52
[7]   Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia [J].
Brown, Jennifer R. ;
Hanna, Megan ;
Tesar, Bethany ;
Werner, Lillian ;
Pochet, Nathalie ;
Asara, John M. ;
Wang, Yaoyu E. ;
dal Cin, Paola ;
Fernandes, Stacey M. ;
Thompson, Christina ;
MacConaill, Laura ;
Wu, Catherine J. ;
Van de Peer, Yves ;
Correll, Mick ;
Regev, Aviv ;
Neuberg, Donna ;
Freedman, Arnold S. .
CLINICAL CANCER RESEARCH, 2012, 18 (14) :3791-3802
[8]   Individuals with &ITFANCM&IT biallelic mutations do not develop Fanconi anemia, but show risk for breast cancer, chemotherapy toxicity and may display chromosome fragility [J].
Catucci, Irene ;
Osorio, Ana ;
Arver, Brita ;
Neidhardt, Guido ;
Bogliolo, Massimo ;
Zanardi, Federica ;
Riboni, Mirko ;
Minardi, Simone ;
Pujol, Roser ;
Azzollini, Jacopo ;
Peissel, Bernard ;
Manoukian, Siranoush ;
De Vecchi, Giovanna ;
Casola, Stefano ;
Hauke, Jan ;
Richters, Lisa ;
Rhiem, Kerstin ;
Schmutzler, Rita K. ;
Wallander, Karin ;
Torngren, Therese ;
Borg, Ake ;
Radice, Paolo ;
Surralles, Jordi ;
Hahnen, Eric ;
Ehrencrona, Hans ;
Kvist, Anders ;
Benitez, Javier ;
Peterlongo, Paolo .
GENETICS IN MEDICINE, 2018, 20 (04) :452-457
[9]   The Fanconi anaemia pathway: newyplayers and new functions [J].
Ceccaldi, Raphael ;
Sarangi, Prabha ;
D'Andrea, Alan D. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2016, 17 (06) :337-349
[10]   Selective Killing of SMARCA2-and SMARCA4-deficient Small Cell Carcinoma of the Ovary, Hypercalcemic Type Cells by Inhibition of EZH2: In Vitro and In Vivo Preclinical Models [J].
Chan-Penebre, Elayne ;
Armstrong, Kelli ;
Drew, Allison ;
Grassian, Alexandra R. ;
Feldman, Igor ;
Knutson, Sarah K. ;
Kuplast-Barr, Kristy ;
Roche, Maria ;
Campbell, John ;
Ho, Peter ;
Copeland, Robert A. ;
Chesworth, Richard ;
Smith, Jesse J. ;
Keilhack, Heike ;
Ribich, Scott A. .
MOLECULAR CANCER THERAPEUTICS, 2017, 16 (05) :850-860